医药政策法规
- (2022-01-24)
- (2022-01-23)
- (2022-01-23)
- (2022-01-23)
- (2022-01-23)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-22)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
双重免疫一线治疗肝癌(HCC)！阿斯利康Imfinzi tremelimumab方案显示了前所未有的生存益处:3年生存率为31%！
(2022-01-20)- (2022-01-20)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-16)
- (2022-01-16)
- (2022-01-16)
 |
 |
| 解决便秘的偏方 | 女孩向往 |
 |
 |
| 婴儿出生时瞬间 | 西红柿养生功效 |
 医药新闻 |
| 医疗健康 |
| 健康之路 |
| 医药政策法规 |
|||||||||||
|
